We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
GE Healthcare Launches DeCyder 2D 7.1 SPN Software for HCP Quantitation and Characterization
Product News

GE Healthcare Launches DeCyder 2D 7.1 SPN Software for HCP Quantitation and Characterization

GE Healthcare Launches DeCyder 2D 7.1 SPN Software for HCP Quantitation and Characterization
Product News

GE Healthcare Launches DeCyder 2D 7.1 SPN Software for HCP Quantitation and Characterization


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "GE Healthcare Launches DeCyder 2D 7.1 SPN Software for HCP Quantitation and Characterization"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

GE Healthcare has launched DeCyder 2D 7.1 SPN software, specifically designed to support 2-D DIGE for the characterization and quantitation of Host Cell Proteins (HCPs). HCP profiling is a critical Quality Assurance parameter associated with product safety during biopharmaceutical processing.

The software package offers an antibody-independent procedure to enable direct comparisons of individual target protein/HCP profiles between samples taken from distinctly different steps of a process. This capability increases process understanding, and facilitates process optimization and Quality by Design.

HCP profiling using 2-D DIGE is used in early process development, where it is critical to be able to track HCP changes resulting from process parameter changes. It is also used at several steps of the scale up process, from process development through to manufacturing, and can validate the use of ELISA in downstream processing.
Advertisement